98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1056/NEJMc2314334 | DOI Listing |
N Engl J Med
June 2024
deCODE Genetics-Amgen, Reykjavik, Iceland
Mol Neurodegener
February 2023
Department of Neurobiology and Behavior, University of California, Irvine, USA.
Background: The TREM2 R47H variant is one of the strongest genetic risk factors for late-onset Alzheimer's Disease (AD). Unfortunately, many current Trem2 mouse models are associated with cryptic mRNA splicing of the mutant allele that produces a confounding reduction in protein product. To overcome this issue, we developed the Trem2 (Normal Splice Site) mouse model in which the Trem2 allele is expressed at a similar level to the wild-type Trem2 allele without evidence of cryptic splicing products.
View Article and Find Full Text PDF